{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:59:27Z","timestamp":1791388767446,"version":"4.3.3"},"reference-count":75,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00450","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T05:30:35Z","timestamp":1475213435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental Disorders"],"prefix":"10.3389","volume":"10","author":[{"given":"Cyrus","family":"Vahdatpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam H.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tropea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1100\/tsw.2006.22","article-title":"Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain","volume":"6","author":"Aberg","year":"2006","journal-title":"ScientificWorldJournal"},{"key":"B2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-2007-990282","article-title":"Urinary epidermal and insulin-like growth factor excretion in autistic children","volume":"38","author":"Anlar","year":"2007","journal-title":"Neuropediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/08830738050200082401","article-title":"Neuropathology of Rett syndrome","volume":"20","author":"Armstrong","year":"2005","journal-title":"J. Child Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0169-328X(91)90054-2","article-title":"Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain","volume":"10","author":"Bach","year":"1991","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"34","key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2012.00034","article-title":"Rett syndrome: genes, synapses, circuits, and therapeutics","volume":"3","author":"Banerjee","year":"2012","journal-title":"Front. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0169-328X(92)90131-T","article-title":"Expression of IGF-1 mRNA in the murine subventricular zone during postnatal development","volume":"12","author":"Bartlett","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0896-6273(95)90216-3","article-title":"Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons","volume":"14","author":"Beck","year":"1995","journal-title":"Neuron"},{"key":"B8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-neuro-060909-153138","article-title":"The pathophysiology of fragile X (and what it teaches us about synapses)","volume":"35","author":"Bhakar","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"B9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1993.tb26203.x","article-title":"Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications","volume":"692","author":"Bondy","year":"1993","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2040-2392-4-9","article-title":"Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay","volume":"4","author":"Bozdagi","year":"2013","journal-title":"Mol. Autism"},{"key":"B12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Cahrour","year":"2007","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","author":"Centers for Disease Control Prevention","year":"2012","journal-title":"Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years\u2014Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2009.05.001","article-title":"Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations","volume":"35","author":"Chapleau","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/08977190701602329","article-title":"Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent","volume":"25","author":"Chen","year":"2007","journal-title":"Growth Factors"},{"key":"B19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0303-7207(98)00024-0","article-title":"Role of insulin-like growth factor binding proteins in the control of IGF actions","volume":"140","author":"Clemmons","year":"1998","journal-title":"Mol. Cell. Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.029","article-title":"Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms","volume":"520","author":"Corvin","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s13311-015-0352-z","article-title":"The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders","volume":"12","author":"Costales","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"46","key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00046","article-title":"Resilience to audiogenic seizures is associated with p-ERK1\/2 dephosphorylation in the subiculum of Fmr1 knockout mice","volume":"25","author":"Curia","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12017-015-8341-2","article-title":"NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome","volume":"17","author":"Deacon","year":"2015","journal-title":"Neuromol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopsych.2015.08.028","article-title":"Dendritic spine instability in a mouse model of CDKL5 disorder is rescued by insulin-like growth factor 1. Mol","volume":"80","author":"Della Sala","year":"2016","journal-title":"P"},{"key":"B26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2012.12.018","article-title":"FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels","volume":"77","author":"Deng","year":"2013","journal-title":"Neuron"},{"key":"B27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature13772","article-title":"Synaptic, transcriptional and chromatin genes disrupted in autism","volume":"515","author":"De Rubeis","year":"2014","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuroscience.2006.02.084","article-title":"Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function","volume":"140","author":"Ding","year":"2006","journal-title":"Neuroscience"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2","volume":"76","author":"Durand","year":"2012","journal-title":"Neuron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","article-title":"The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity","volume":"325","author":"Dyer","year":"2016","journal-title":"Nueroscience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.mp.4001896","article-title":"The genetics of autistic disorders and its clinical relevance: a review of the literature","volume":"12","author":"Freitag","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1586\/14737159.2016.1135739","article-title":"Fragile X syndrome","volume":"16","author":"Garber","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.1523\/JNEUROSCI.0402-10.2010","article-title":"Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome","volume":"30","author":"Gross","year":"2010","journal-title":"J. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0306-4522(98)00338-8","article-title":"The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats","volume":"89","author":"Guan","year":"1999","journal-title":"Neuroscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Disabil. Res. Rev."},{"key":"B38","first-page":"129","article-title":"Fragile X syndrome. molecular and clinical insights and treatment issues","volume":"166","author":"Hagerman","year":"1997","journal-title":"West J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2202-15-91","article-title":"IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells","volume":"15","author":"Huat","year":"2014","journal-title":"BMC Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2040-2392-2-1","article-title":"A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism","volume":"2","author":"Hussman","year":"2011","journal-title":"Mol. Autism"},{"key":"B41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1210\/er.20.6.761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","article-title":"Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains","volume":"66","author":"Itoh","year":"2007","journal-title":"Neuropathol. Exp. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/adc.85.1.29","article-title":"Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder","volume":"85","author":"Julu","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"B44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tins.2015.12.008","article-title":"Rett syndrome: crossing the threshold to clinical translation","volume":"39","author":"Katz","year":"2016","journal-title":"Trends Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.braindev.2004.10.008","article-title":"MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution","volume":"27","author":"Kaufmann","year":"2005","journal-title":"Brain Dev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome","volume":"111","author":"Khwaja","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/2040-2392-5-54","article-title":"A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome","volume":"5","author":"Kolevzon","year":"2014","journal-title":"Mol. Autism"},{"key":"B48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1073858408331371","article-title":"Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis","volume":"15","author":"Llorens-Mart\u00edn","year":"2009","journal-title":"Neuroscientist"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.95","article-title":"Altered proliferation and networks in neural cells derived from idiopathic autistic individuals","author":"Marchetto","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1365-2265.2007.02868.x","article-title":"Elevated levels of growth-related hormones in autism and autism spectrum disorder","volume":"67","author":"Mills","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.beem.2010.08.005","article-title":"IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development","volume":"25","author":"Netchine","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1210\/endo-127-3-1260","article-title":"Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system","volume":"127","author":"Ocrant","year":"1990","journal-title":"Endocrinology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yfrne.2012.06.002","article-title":"Neurodevelopmental effects of insulin-like growth factor signaling","volume":"33","author":"O'Kusky","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrhophic factor across the blood brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Nueropharmacology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1023\/A:1018940732550","article-title":"Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery","volume":"11","author":"Pardridge","year":"1994","journal-title":"Pharm. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/01.mop.0000143693.59408.ce","article-title":"Rett syndrome: clinical and molecular update","volume":"16","author":"Percy","year":"2004","journal-title":"Curr. Opin. Paediatr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000334260","article-title":"The 22q13.3 deletion syndrome (Phelan-McDermid syndrome)","volume":"2","author":"Phelan","year":"2012","journal-title":"Mol. Syndromol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5073078","DOI":"10.1155\/2016\/5073078","article-title":"Illness severity, social and cognitive ability, and EEG analysis of ten patients with rett syndrome treated with mecasermin (recombinant human IGF-1)","volume":"2016","author":"Pini","year":"2016","journal-title":"Autism Res. Treat."},{"issue":"52","key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00052","article-title":"Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study","volume":"2","author":"Pini","year":"2014","journal-title":"Front. Paediatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"679801","DOI":"10.1155\/2012\/679801","article-title":"IGF1 as a potential treatment for rett syndrome: safety assessment in six rett patients","volume":"2012","author":"Pini","year":"2012","journal-title":"Autism Res. Treat."},{"key":"B61","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/j.0953-816X.2004.03320.x","article-title":"In vivo effects of insulin-like growth factor-I (IGF-I) on prenatal and early postnatal development of the central nervous system","volume":"19","author":"Popken","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1017\/S0012162201001116","article-title":"Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism","volume":"43","author":"Riikonen","year":"2001","journal-title":"Dev. Med. Chlild Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1523\/jneurosci.4354-04.2005","article-title":"Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons","volume":"25","author":"Roussignol","year":"2005","journal-title":"J. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature12618","article-title":"SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients","volume":"503","author":"Shcheglovitov","year":"2013","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"522","DOI":"10.7150\/ijms.5325","article-title":"IGF-1 acts as controlling switch for long-term proliferation and maintenance of EGF\/FGF-responsive striatal neural stem cells","volume":"10","author":"Supeno","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2016.04.024","article-title":"Expression of nuclear Methyl-CpG binding protein 2 (Mecp2) is dependent on neuronal stimulation and application of Insulin-like growth factor 1","volume":"621","author":"Tropea","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1017\/S0012162206001605","article-title":"Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism","volume":"48","author":"Vanhala","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"issue":"183","key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00183","article-title":"Autism spectrum disorders: emerging mechanisms and mechanism-based treatment","volume":"9","author":"Wang","year":"2015","journal-title":"Front. Cell Neursci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature07999","article-title":"Common genetic variants on 5p14.1 associate with autism spectrum disorders","volume":"459","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ajmg.b.30765","article-title":"Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome","volume":"147B","author":"Weng","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/jnr.21289","article-title":"Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampus","volume":"85","author":"Zhang","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","article-title":"Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation","volume":"52","author":"Zhou","year":"2006","journal-title":"Neuron"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:03:26Z","timestamp":1498334606000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fnins.2016.00450\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":75,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00450","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,30]]}}}